Interactions Between Aging and Alzheimer's Disease on Structural Brain Networks
Zhanxiong Wu1, Yunyuan Gao2, Thomas Potter3
1School of Electronic Information, Hangzhou Dianzi University, Hangzhou, China.
Frontiers in Aging Neuroscience
|June 28, 2021
Summary
Aging and Alzheimer's disease (AD) interact to affect brain networks. While global network measures show age-related decline in AD, specific brain regions show combined aging and AD effects on connectivity, impacting cognitive function.
Area of Science:
- Neuroscience
- Medical Imaging
- Network Science
Background:
- Normative aging and Alzheimer's disease (AD) impact brain structure and function.
- The interplay between aging and AD on brain network topology remains unclear.
Purpose of the Study:
- To investigate the combined effects of aging and AD on the structural brain network topology.
- To analyze alterations in global and nodal network properties in relation to age and AD progression.
Main Methods:
- Utilized diffusion-weighted MRI data from 139 subjects (controls, early/late MCI, AD) from the ADNI database.
- Constructed structural brain networks using anatomically-constrained deterministic tractography.
- Assessed global and nodal topological properties and analyzed interactions using linear regression and ANOVA.
Main Results:
- No significant interactions between aging and AD were found for global network metrics (e.g., network efficiency, transitivity).
- Significant interactions were observed in nodal metrics, specifically the clustering coefficient and betweenness centrality, in regions like the left superior temporal and right precentral parcels.
- Confirmed age-related deterioration of structural networks in mild cognitive impairment (MCI) and AD patients.
Conclusions:
- Aging and AD interact to alter brain network topology, particularly at the nodal level.
- Nodal network changes in specific cortical regions may underlie early AD symptoms due to combined age-associated vulnerability and AD pathology.
- Findings provide insights into the complex relationship between aging, AD, and brain network integrity.
Related Concept Videos
Alzheimer's Disease: Overview
923
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
923
Aging
368
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
368
Alzheimer's Disease: Treatment
444
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
444
The Effect of Aging on Tissues
2.9K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.9K
Pharmacodynamics in Geriatric Patients: Effects of Age
55
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
55
Cognitive Development During Adulthood
429
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
429


